Use of nivolumab (N) and cabozantinib (C) for treatment of the metastatic renal cell carcinoma (mRCC) in the Veneto region: Results of AMOUR study.-MedSci.cn

Use of nivolumab (N) and cabozantinib (C) for treatment of the metastatic renal cell carcinoma (mRCC) in the Veneto region: Results of AMOUR study.

Maruzzo, M; Bortolami, A; Palleschi, D; Zivi, A; Nicodemo, M; Sartori, D; De Vivo, R; Zustovich, F; Bimbatti, D; Pastorelli, D; Vultaggio, GD; Soraru, M; Ballestrin, M; Zanchetta, G; Modonesi, C; Randisi, P; Barile, C; Perri, G; Basso, U; Zagonel, V

JOURNAL OF CLINICAL ONCOLOGY, 2021; 39 (6):

科室
- - 订阅+
  - 更多科室
工具
服务